Comparison of Vaccine Effectiveness Against the Omicron (B.1.1.529) Variant in Hemodialysis Patients

Kidney Int Rep. 2022 Jun;7(6):1406-1409. doi: 10.1016/j.ekir.2022.04.005. Epub 2022 Apr 13.

Authors

Katrina J Spensley^{1

2}, Sarah Gleeson², Paul Martin², Tina Thomson², Candice L Clarke^{1

2}, Graham Pickard³, David Thomas^{1

2}, Stephen P McAdoo^{1

2}, Paul Randell³, Peter Kelleher^{3

4}, Rachna Bedi², Liz Lightstone^{1

2}, Maria Prendecki^{1

2}, Michelle Willicombe^{1

2}

Affiliations

¹ Centre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College London, London, UK.
² Imperial College Renal and Transplant Center, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK.
³ Department of Infection and Immunity Sciences Northwest London Pathology NHS Trust, Charing Cross Hospital, London, UK.
⁴ Department of Infectious Diseases, Imperial College London, London, UK.

No abstract available

Keywords: COVID-19; SARS-CoV-2; haemodialysis.

Grants and funding

WT_/Wellcome Trust/United Kingdom